Triethylene Glycol

Triethylene Glycol

SCHEMBL464912

CCC1(COCC2(CC)COC2)COC1.OCCOCCOCCO

nearest known ligand 0.41

Full drug profile on Sugi Atlas →

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
THRB P10828 1/20 0.38
HTT P42858 1/20 0.38
MAPT P10636 1/20 0.38
TSHR P16473 3/20 0.38
MAPK1 P28482 1/20 0.37
ALDH1A1 P00352 1/20 0.37
EPHX1 P07099 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Tetraethylene Glycol SCHEMBL464913 1.00 MEN1 (0.41) MEN1KMT2ATHRBHTTMAPT
Di(Hydroxyethyl)Ether SCHEMBL20676740 0.98 TSHR (0.39) MEN1KMT2ATHRBHTTMAPT
SCHEMBL2991699 0.96 MEN1 (0.41) MEN1KMT2ATHRBHTTMAPT
SCHEMBL216524 0.92 ALDH1A1 (0.39) MEN1KMT2ATHRBHTTMAPT
SCHEMBL16274861 0.91 MEN1 (0.37) MEN1KMT2ATHRBHTTMAPT
Ethylene Glycol SCHEMBL464873 0.88 EPHX1 (0.39) MEN1KMT2ATSHREPHX1
SCHEMBL2830527 0.86 TSHR (0.33) TSHREPHX1
SCHEMBL2830458 0.86 TSHR (0.33) TSHREPHX1
SCHEMBL217129 0.86 TSHR (0.33) TSHREPHX1
SCHEMBL216342 0.86 TSHR (0.33) TSHREPHX1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 202 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260139710-A1 BEARING DEVICE, METHOD OF MANUFACTURING BEARING DEVICE, HARD DISK DRIVE DEVICE, AND MOTOR MINEBEA MITSUMI INC (JP) 2026-05-21 US disclosed
WO-2025121228-A1 OLEFIN-OXETANE COMPOUND, METHOD FOR SYNTHESIZING SAID OLEFIN-OXETANE COMPOUND AND USE THEREOF 四国化成工業株式会社 2025-06-12 WO disclosed
WO-2025121227-A1 CURABLE COMPOSITION, CURED PRODUCT, ADHESIVE, AND SEALANT 四国化成工業株式会社 2025-06-12 WO disclosed
US-12264073-B2 Composite material ADEKA CORPORATION (JP) 2025-04-01 US disclosed
US-20250066548-A1 HYBRID PHOTOCURABLE COMPOSITION ARKEMA FRANCE (FR) 2025-02-27 US disclosed
WO-2025028383-A1 CURABLE COMPOSITION, CURABLE INK COMPOSITION, CURABLE INKJET INK COMPOSITION, AND USE THEREOF 四国化成工業株式会社 2025-02-06 WO disclosed
WO-2024247919-A1 AZOLE COMPOUND, METHOD FOR SYNTHESIZING SAID AZOLE COMPOUND, AND USE THEREOF 四国化成工業株式会社 2024-12-05 WO disclosed
WO-2024204797-A1 PHOTOSENSITIVE COLORING COMPOSITION FOR ORGANIC EL DISPLAY DEVICES, PHOTOSENSITIVE COLORING COMPOSITION FOR MICRO-LED DISPLAY DEVICES, CURED FILM, ORGANIC EL DISPLAY DEVICE, AND MICRO-LED DISPLAY DEVICE artience株式会社 2024-10-03 WO disclosed
WO-2024204795-A1 ORGANIC EL DISPLAY DEVICE AND MICRO-LED DISPLAY DEVICE artience株式会社 2024-10-03 WO disclosed
EP-3010943-B1 CURABLE COMPOSITION, FILM, AND METHOD OF PRODUCING FILM CANON KK (JP) 2024-04-03 EP disclosed
EP-1295899-A2 Active energy beam-curable composition, ink containing the same, and printer accommodating the same ink BROTHER KOGYO KABUSHIKI KAISHA (JP) 2003-03-26 EP disclosed
EP-1277776-A1 Photocurable resin composition for sealing material and method of sealing Mitsui Chemicals, Inc. (JP) 2003-01-22 EP disclosed
EP-1254193-A1 REACTIVE PARTICLES, CURABLE COMPOSITION COMPRISING THE SAME AND CURED PRODUCTS DSM N.V. (NL) 2002-11-06 EP disclosed
US-6365644-B1 TO PROVIDE CURED PRODUCT HAVING MECHANICAL STRENGTH AND MINIMIZED SHRINKAGE DURING CURING TO ENSURE HIGH DIMENSIONAL ACCURACY DSM N.V. (NL) 2002-04-02 US disclosed
WO-2001095030-A2 RESIN COMPOSITION AND THREE-DIMENSIONAL OBJECT DSM N.V. (NL) 2001-12-13 WO disclosed
EP-0848294-B1 Photo-curable resin composition used for photo-fabrication of three-dimensional objects DSM NV (NL) 2001-09-19 EP disclosed
WO-2001048073-A1 REACTIVE PARTICLES, CURABLE COMPOSITION COMPRISING THE SAME AND CURED PRODUCTS DSM N.V. (NL) 2001-07-05 WO disclosed
WO-2000049080-A1 PHOTO CURABLE LIQUID RESIN COMPOSITION AND PHOTOFABRICATED CURED PRODUCT DSM N.V. (NL) 2000-08-24 WO disclosed
US-5981616-A OXETANE COMPOUND, EPOXY COMPOUND CONSISTING OF EXPOXIDIZED POLYMERS OF CONJUGATED DIENE MONOMERS, EXPOXIDIZED COPOLYMERS OF DIENE MONOMERS AND COMPOUNDS HAVING AN ETHYLENICALLY UNSATURATED BOND, AND EXPOXIDIZED NATURAL RUBBER DSM N.V. (NL) 1999-11-09 US disclosed
EP-0848294-A1 Photo-curable resin composition used for photo-fabrication of three-dimensional objects DSM N.V. (NL) 1998-06-17 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260139710-A1 BEARING DEVICE, METHOD OF MANUFACTURING BEARING DEVICE, HARD DISK DRIVE DEVICE, AND MOTOR ZW10, SOD1, EED MEN1 2897/4885KMT2A 1023/4885THRB 4734/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.